Connor, Clark & Lunn Investment Management (CC&L)’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $1.22M | Buy |
|
|||||
|
2024
Q4 | $665K | Sell |
|
|||||
|
2024
Q3 | $21.6M | Buy |
|
|||||
|
2024
Q2 | $9.99M | Buy |
|
|||||
|
2024
Q1 | $1.93M | Sell |
|
|||||
|
2023
Q4 | $1.92M | Sell |
|
|||||
|
2023
Q3 | $2.19M | Sell |
|
|||||
|
2023
Q2 | $12.2M | Sell |
|
|||||
|
2023
Q1 | $24.5M | Buy |
|
|||||
|
2022
Q4 | $13.1M | Buy |
|
|||||
|
2022
Q3 | $2.92M | Buy |
|
|||||
|
2022
Q2 | $1.85M | Sell |
|
|||||
|
2022
Q1 | $5.82M | Sell |
|
|||||
|
2021
Q4 | $11.2M | Buy |
|
|||||
|
2021
Q3 | $7.18M | Sell |
|
|||||
|
2021
Q2 | $14M | Sell |
|
|||||
|
2021
Q1 | $12.3M | Buy |
|
|||||
|
2020
Q4 | $4.01M | Buy |
|
|||||
|
2020
Q3 | $4.01M | Buy |
|
|||||
|
2020
Q2 | $3.02M | Buy |
|
|||||
|
2020
Q1 | $1.92M | Sell |
|
|||||
|
2019
Q4 | $7.51M | Buy |
|
|||||
|
2019
Q3 | $1.48M | Sell |
|
|||||
|
2019
Q2 | $5.49M | Buy |
|
|||||
|
2019
Q1 | $1.81M | Buy |
|
|||||
|
2018
Q4 | $1.05M | Sell |
|
|||||
|
2018
Q3 | $1.8M | Buy |
|
|||||
|
2018
Q2 | $1.32M | Sell |
|
|||||
|
2018
Q1 | $1.46M | Sell |
|
|||||
|
2017
Q4 | $1.86M | Buy |
|
|||||
|
2017
Q3 | $2.2M | Buy |
|
|||||
|
2017
Q2 | $2.11M | Buy |
|
|||||
|
2017
Q1 | $1.32M | Sell |
|
|||||
|
2016
Q4 | $1.87M | Buy |
|
|||||
|
2016
Q3 | $1.21M | Sell |
|
|||||
|
2016
Q2 | $1.85M | Buy |
|
|||||
|
2016
Q1 | $1.8M | Sell |
|
|||||
|
2015
Q4 | $6.35M | Sell |
|
|||||
|
2015
Q3 | $9.24M | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $3.14M | Buy |
|
|||||
|
2013
Q3 | $1.91M | Buy |
|
|||||
|
2013
Q2 | $285K | Buy |
|